
Oral anticoagulants found to be more effective and cost-effective than heparin for cancer-associated thrombosis
A cost-effectiveness analysis comparing direct oral anticoagulants (DOACs) to low-molecular-weight heparin (LMWH) found that DOACs are both more medically effective and cost-effective than LMWH when treating cancer-associated ...
Dec 26, 2022
0
18